General Information of This Antibody-drug Conjugate (ID: DRG0SBFHC)
ADC Name
GR1017
Synonyms
GR1017; AMB302; GQ1011; BHV-1530
   Click to Show/Hide
Organization
Aimed Bio (Originator);GeneQuantum Healthcare;Biohaven;KDDF
Drug Status
Phase 1
Antibody Name
AimedBio
 Antibody Info 
Antigen Name
Fibroblast growth factor receptor 3 (FGFR3)
 Antigen Info 
Payload Name
TOP1 inhibitor
 Payload Info 
Payload Target
DNA topoisomerase 1 (TOP1)
 Target Info 
Linker Name
A cleavable linker
 Linker Info 
Conjugate Type
Enzymatic Catalysis
Combination Type
TopoIx
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC
Indication Phase 1 Phase 2 Phase 3 Approved
Unspecific solid tumor
1 Trials
Trial ID
NCT06874335
Lung cancer
1 Trials
Trial ID
NCT06874335
Urothelial cancer
1 Trials
Trial ID
NCT06874335
Head and neck cancer
1 Trials
Trial ID
NCT06874335